Nitazoxanide for COVID-19 Treatment: Regulatory Status Update
Emergency use authorization for nitazoxanide as a potential treatment for COVID-19 is requested from the FDA in the US, signaling ongoing efforts to repurpose existing drugs for combating the pandemic and expanding therapeutic options for affected individuals.
January 2022
Excessive Daytime Sleepiness: Challenges in Epidemiological Assessment and Clinical Management
Epidemiological studies on excessive daytime sleepiness (EDS) have utilized various definitions, limiting comparability across studies and highlighting the need for standardized assessment tools and consensus criteria to improve diagnostic accuracy and treatment outcomes in affected individuals.
January 2022
Increased Screen Time and Sleep Problems during the Pandemic: Implications for Mental Health
Increased screen time at night during COVID-19 lockdown negatively affects sleep quality, emphasizing the importance of establishing healthy screen habits and promoting sleep hygiene practices to mitigate mental health consequences of prolonged digital exposure.
January 2022
COVID-19 Vaccination in Breastfeeding Women: Insights from Antibody Secretion in Breast Milk
Breast milk from vaccinated mothers shows strong secretion of SARS-CoV-2-specific IgA and IgG antibodies for up to 6 weeks post-vaccination, supporting the safety and efficacy of COVID-19 vaccination in breastfeeding women and passive immunity transfer to infants.
December 2021
Role of Pharmacists in Primary Health Care: Team-Based Approach
A team-based approach to primary health care, involving pharmacists as integral members, enhances patient outcomes and improves healthcare delivery, underscoring the importance of interdisciplinary collaboration in optimizing patient care and medication management.
December 2021
